These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 1756519

  • 1. Severe hyperlipidemia due to multiple factors in a child with nephrotic syndrome.
    Ongkingco JR, Mann WA, Ruley EJ, Gregg RE.
    Child Nephrol Urol; 1991; 11(2):107-10. PubMed ID: 1756519
    [Abstract] [Full Text] [Related]

  • 2. [Hyperlipidemia in nephrotic syndrome].
    Heaf JG.
    Ugeskr Laeger; 1991 Aug 26; 153(35):2414-6. PubMed ID: 1949240
    [Abstract] [Full Text] [Related]

  • 3. Rationale and management of hyperlipidemia of the nephrotic syndrome.
    Grundy SM, Vega GL.
    Am J Med; 1989 Nov 26; 87(5N):3N-11N. PubMed ID: 2486542
    [Abstract] [Full Text] [Related]

  • 4. Long term prognosis of the nephrotic syndrome in childhood.
    Schärer K, Minges U.
    Clin Nephrol; 1973 Nov 26; 1(3):182-7. PubMed ID: 4783717
    [No Abstract] [Full Text] [Related]

  • 5. Premature acute myocardial infarction in a child with nephrotic syndrome.
    Silva JM, Oliveira EA, Marino VS, Oliveira JS, Torres RM, Ribeiro AL, Simal CJ, Ribeiro MC.
    Pediatr Nephrol; 2002 Mar 26; 17(3):169-72. PubMed ID: 11956853
    [Abstract] [Full Text] [Related]

  • 6. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis.
    Kes P.
    Acta Med Croatica; 2001 Mar 26; 55(4-5):177-86. PubMed ID: 12398021
    [Abstract] [Full Text] [Related]

  • 7. Hyperlipidemia of the nephrotic syndrome.
    Kaysen GA.
    Kidney Int Suppl; 1991 Apr 26; 31():S8-15. PubMed ID: 2046275
    [No Abstract] [Full Text] [Related]

  • 8. [Recent trends in the therapy of hyperlipidemia in nephrotic syndrome].
    Campanacci L, Guarnieri GF, Faccini L, Bellini G, Gambari PF.
    G Clin Med; 1973 Oct 26; 54(10):714-33. PubMed ID: 4789301
    [No Abstract] [Full Text] [Related]

  • 9. [Mutual relation between hyperlipidemia and nephrotic syndrome].
    Kraise Y, Averbuch M, Schwartz D, Kornovsky R, Levo Y.
    Harefuah; 1991 Dec 15; 121(12):521-4. PubMed ID: 1794760
    [No Abstract] [Full Text] [Related]

  • 10. [Activity of the clearing factor in the pathogenesis of hyperlipidemia in experimental nephrotic syndrome].
    Nikiforova NV.
    Biull Eksp Biol Med; 1966 Dec 15; 62(12):29-32. PubMed ID: 6005418
    [No Abstract] [Full Text] [Related]

  • 11. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P, Reiner Z, Brunetta B.
    Lijec Vjesn; 2002 Dec 15; 124(11-12):372-7. PubMed ID: 12679979
    [Abstract] [Full Text] [Related]

  • 12. The effects of gemfibrozil on hyperlipidemia in children with persistent nephrotic syndrome.
    Büyükçelik M, Anarat A, Bayazit AK, Noyan A, Ozel A, Anarat R, Aydingülü H, Dikmen N.
    Turk J Pediatr; 2002 Dec 15; 44(1):40-4. PubMed ID: 11858378
    [Abstract] [Full Text] [Related]

  • 13. Management of hyperlipidemia of kidney disease.
    Grundy SM.
    Kidney Int; 1990 Mar 15; 37(3):847-53. PubMed ID: 2179614
    [No Abstract] [Full Text] [Related]

  • 14. Hyperlipidemia as the first biochemical manifestation of primary hepatic amyloidosis.
    Couture P, LeBlanc F, Gagnon P, Gagnon O, Gagné C.
    Am J Gastroenterol; 1997 Jun 15; 92(6):1046-7. PubMed ID: 9177530
    [No Abstract] [Full Text] [Related]

  • 15. Molecular basis of steroid-resistant nephrotic syndrome.
    Antignac C.
    Nefrologia; 2005 Jun 15; 25 Suppl 2():25-8. PubMed ID: 16050398
    [Abstract] [Full Text] [Related]

  • 16. Apolipoprotein E polymorphism in childhood nephrotic syndrome.
    Attila G, Noyan A, Karabay Bayazit A, Acartürk E, Anarat A.
    Pediatr Nephrol; 2002 May 15; 17(5):359-62. PubMed ID: 12042894
    [Abstract] [Full Text] [Related]

  • 17. Nephrotic syndrome associated with severe hypertriglyceridemia in a pediatric patient: Answers.
    Corredor-Andrés B, Muñoz-Calvo MT, Calero O, Aparicio C, Argente J, Calero M.
    Pediatr Nephrol; 2018 Nov 15; 33(11):2075-2078. PubMed ID: 29532233
    [No Abstract] [Full Text] [Related]

  • 18. The influence of apoprotein epsilon 2 homozygosity on nephrotic hyperlipidemia.
    Joven J, Vilella E.
    Clin Nephrol; 1997 Sep 15; 48(3):141-5. PubMed ID: 9342484
    [Abstract] [Full Text] [Related]

  • 19. Acute myocardial infarction in a young boy with nephrotic syndrome: a case report and review of the literature.
    Hopp L, Gilboa N, Kurland G, Weichler N, Orchard TJ.
    Pediatr Nephrol; 1994 Jun 15; 8(3):290-4. PubMed ID: 7917853
    [Abstract] [Full Text] [Related]

  • 20. [Hyperlipidemia in kidney diseases].
    Saito T.
    Nihon Rinsho; 2007 Jul 28; 65 Suppl 7():407-11. PubMed ID: 17824062
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.